TPBC LogoTPBC Home PageTPBC NewslettersLinks to Talking PointsContact Texas Pharmacy Business Council

Original Circle R logo

July 20, 2010

 

 

Texas Pharmacy Business Council is an organization of American Pharmacies and the Academy of Independent Pharmacists-Texas.

 

 

In this issue

 

 

 

Forward this email to a Friend

 

 

link1TDI pharmacy help

The Texas Department of Insurance has a Pharmacist Resource Page that includes links to complaint forms and advises when the next Pharmacy Outreach Conference Call will be held.

Add this link to your online "favorites" list.

Save this link for complaints about discount health care operators.

 

 

link22009 Texas legislation successes

 

Regulation of Rx discount cards

 PBM transparency in state contracts

Mail order parity

 

 


link

becks

link3State Board of Pharmacy urged to create pharmacy advisory board


Rather than waiting for the comment period post publication in the Texas Register, we are asking the Texas State Board of Pharmacy to create an advisory panel to help write the rules affecting community pharmacy. We also requested this topic be added to the agenda for the next TSBP board meeting.

I sent a letter Wednesday to TSBP President Jeanne D. Waggener, RPh, noting the successes of previous panels and task forces and urging creation of such a panel for Class A licensed pharmacies. We suggest that the advisory panel be comprised of six licensed Class A community pharmacists in good standing, as well as two Texas Pharmacy Business Council board members plus appropriate Council staff.

It is our expectation that such a partnership and alliance between the community pharmacy profession and the TSBP via this advisory panel ultimately will result in a significantly more efficient and less adversarial rule-making process. It also will benefit the patients we serve.  

Stay tuned!


Richard's signature
Richard E. Beck, RPh
Executive Director, Texas Pharmacy Business Council

 

 

link4Test revised Vendor Drug specifications
beginning Friday

The revised Vendor Drug Payer Specification Sheets are now available for changes that go into effect Monday, August 23.

Pharmacies must communicate these changes to their switch company and software vendor as soon as possible, and submit test claims to ensure the software is set up properly. Tests can be submitted beginning Friday and continuing through Aug. 22. All changes go live Aug. 23.

Pharmacies will continue to use the National Council for Prescription Drug Programs version 5.1 software format for all billing (B1), reversal (B2), and eligibility verification (E1) transactions for Medicaid, Children's Health Insurance Program, Children with Special Health Care Needs Services Program, and Kidney Health Care program claims.

Test claim information, pharmacy provider training opportunities, and other education materials also are available at the Vendor Drug Program website.

Contact the TMHP-Pharmacy assistance line 24/7 at 877-350-2171 with any questions, including NCPDP error code 99 (Host Processing Error).

 

 

link5DEA weighing changes to "nurse-as-agent" policy in LTCFs

The Drug Enforcement Administration is seeking comments from pharmacists, nurses, and others involved with long-term care facilities on possibly revising its controlled substances policies to better accommodate LTCF residents. Specifically, the DEA is asking if certain persons at LTCFs are designated as prescribers' agents "to communicate controlled substance information from the individual practitioner to the pharmacy, how would this change current practices at your facility for obtaining controlled substance medications for residents? What safeguards should be required?"

DEA's recent re-interpretation of the long-standing "nurse-as-agent" practice has meant that physicians must contact pharmacists directly when a change in a controlled substance pain medication is necessary. Because the pharmacist always needs a hard copy or faxed prescription for C-IIs and the nurse is not allowed to communicate the physician's orders with the pharmacist directly, the pharmacist is forced to track the physician down to get a faxed copy of the prescription.

The National Community Pharmacists Association believes this puts pharmacists in a precarious position in which they are "reduced to threatening prescribers with DEA notification for noncompliance. On one hand, pharmacists risk damaging vital collaborative relationships if they report a physician to the DEA for failing to write the required prescriptions; on the other, they risk losing their right to practice pharmacy if they don't report noncompliant prescribers."

NCPA has recommended that DEA immediately suspend further actions against pharmacies trying to balance the ethical and legal dilemma of not filling a prescription for a resident in pain and violating practice standards or violating DEA's new interpretation of the CSA.

NCPA requests pharmacists with views on this issue to send them to info@ncpanet.org and put LTC in the subject line. Read DEA's June 29 Federal Register Notice here.

Walgreens and CVS Caremark reach agreement
We don't know who blinked first--everyone has a different opinion about it.

Here is what the National Association of Community Pharmacists said about the settlement.

What's the lesson from all this? It reinforces the need for independent community pharmacists to have the right to business negotiations. Walgreens may be a single company negotiating with another single company, but their sheer size means CVS Caremark had to take Walgreens' actions seriously. That kind of clout can't be overestimated. The National Community Pharmacists Association was instrumental in getting a bill introduced in Washington this past session that would have granted the right to negotiate as a group and it was introduced in the health care reform bill, but HR 971 didn't make it to the floor and the language was left out of the health care reform bill. 

Are we disappointed? Yes. Are we discouraged? NO!! This is the kind of battle we'll continue to fight.
Ongoing PBM-related actions in D.C.

Take a moment, please, to call your congressman and ask the s/he becomes a co-sponsor of a congressional letter on H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 which was recently introduced by Reps. Weiner (D-NY) and Moran (R-KS).  This legislation expands the new PBM transparency requirements included in the health care reform bill to all plans both public and private plans.  It is also the first federal legislation to try to reform PBMs' abusive auditing practices.

Do you know how to reach your congressman? Click here to see who represents you in Washington, D.C.

Another step forward regarding PBMs in D.C. is a request sent by U.S. Reps. Peter Welch (D-VT) and Bruce Braley (D-IA) to Chairmen Henry Waxman (D-CA), Frank Pallone, Jr. (D-NJ), and Bart Stupak (D-MI) requesting a hearing in the Energy and Commerce Committee to look into PBMs' aggressive business practices and their impact on patients and pharmacies.  

Texas Pharmacy Business Council
Ensuring patient access to quality pharmacy care services,
the viability of community pharmacy and the pharmacy profession.

1001 Congress Ave., Suite 250, Austin, TX 78701 512.992.1219
Richard E. Beck, RPh, Executive Director
www.TxRxCouncil.org
© 2005 American Pharmacies Inc. | Privacy Policy | Terms of Use